Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.99% sank 0.67% to $416.26 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.58% rising 0.78% to 14,895.12 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.24% rising 0.78% to 35,064.25. The stock's fall snapped a two-day winning streak. Moderna Inc. closed $16.74 short of its 52-week high ($433.00), which the company reached on August 4th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.72% rose 0.03% to $115.12, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.39% rose 2.49% to $233.99, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.21% rose 1.92% to $58.41. Trading volume (25.3 M) eclipsed its 50-day average volume of 14.4 M.